Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.

[1]  C. Ker,et al.  Assessment of serum and bile levels of CA19‐9 and CA125 in cholangitis and bile duct carcinoma , 1991, Journal of gastroenterology and hepatology.

[2]  Y. Nakanuma,et al.  Over‐expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis , 2008, The Journal of pathology.

[3]  Y. Nakanuma,et al.  Carcinoembryonic antigen and blood group‐related carbohydrate antigens in glycoproteins in human bile in hepatolithiasi , 1996, Hepatology.

[4]  Masakazu Yamamoto,et al.  Wisteria floribunda agglutinin‐positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma , 2010, Hepatology.

[5]  Y. Nakanuma,et al.  Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.

[6]  M. Manns,et al.  Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis , 2011, Hepatology.

[7]  S. Shiesh,et al.  The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. , 2002, Hepato-gastroenterology.

[8]  C. Georgopoulos,et al.  Role of the major heat shock proteins as molecular chaperones. , 1993, Annual review of cell biology.

[9]  K. Endo,et al.  Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. , 1990, The American journal of gastroenterology.

[10]  S. Charette,et al.  The Interaction of HSP27 with Daxx Identifies a Potential Regulatory Role of HSP27 in Fas‐Induced Apoptosis , 2000, Annals of the New York Academy of Sciences.

[11]  M. Gleave,et al.  Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells , 2007, Molecular Cancer Therapeutics.

[12]  A. Bergquist,et al.  Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.

[13]  D. Iliopoulos,et al.  Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. , 1989, Journal of the National Cancer Institute.

[14]  Y. Nimura,et al.  Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Y. Atomi,et al.  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria , 2007, Modern Pathology.

[16]  A. Saluja,et al.  Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. , 2009, Gastroenterology.

[17]  Y. Atomi,et al.  Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: Preliminary report based on interobserver agreement , 2005, Pathology international.

[18]  M. Lerch,et al.  Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. , 2007, Cancer research.

[19]  K. Lillemoe,et al.  Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. , 1996, American journal of surgery.

[20]  Y. Nimura,et al.  Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. , 2004, Human pathology.

[21]  Michael Gregor,et al.  Serum and bile markers for cholangiocarcinoma. , 2004, Seminars in liver disease.

[22]  F. Prat,et al.  Bile levels of carcino‐embryonic antigen in patients with hepatopancreatobiliary disease , 1996, European journal of gastroenterology & hepatology.

[23]  C. Lagrasta,et al.  The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma , 2007, BMC Cancer.

[24]  Yabing Chen,et al.  Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma. , 2007, International journal of oncology.

[25]  G. Kroemer,et al.  Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties , 2006, Cell cycle.

[26]  Y. Nakanuma,et al.  Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. , 2008, Human pathology.

[27]  H. Friess,et al.  Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. , 2007, Clinical chemistry.

[28]  Yasunori Sato,et al.  Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. , 2009, World journal of hepatology.